FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283362395> ?p ?o ?g. }

• W4283362395 endingPage "1023" @default.
• W4283362395 startingPage "1023" @default.
• W4283362395 abstract "Mucopolysaccharidosis II (MPS II) is an X-linked disorder resulting from a deficiency in lysosomal enzyme iduronate-2-sulfatase (IDS), which causes the accumulation of glycosaminoglycans (GAGs) in the lysosomes of many tissues and organs, leading to progressive cellular dysfunction. An MPS II newborn screening program has been available in Taiwan since 2015. The aim of the current study was to collect and analyze the long-term follow-up data of the screen-positive subjects in this program.From August 2015 to April 2022, 548,624 newborns were screened for MPS II by dried blood spots using tandem mass spectrometry, of which 202 suspected infants were referred to our hospital for confirmation. The diagnosis of MPS II was confirmed by IDS enzyme activity assay in leukocytes, quantitative determination of urinary GAGs by mass spectrometry, and identification of the IDS gene variant.Among the 202 referred infants, 10 (5%) with seven IDS gene variants were diagnosed with confirmed MPS II (Group 1), 151 (75%) with nine IDS gene variants were classified as having suspected MPS II or pseudodeficiency (Group 2), and 41 (20%) with five IDS gene variants were classified as not having MPS II (Group 3). Long-term follow-up every 6 months was arranged for the infants in Group 1 and Group 2. Intravenous enzyme replacement therapy (ERT) was started in four patients at 1, 0.5, 0.4, and 0.5 years of age, respectively. Three patients also received hematopoietic stem cell transplantation (HSCT) at 1.5, 0.9, and 0.6 years of age, respectively. After ERT and/or HSCT, IDS enzyme activity and the quantity of urinary GAGs significantly improved in all of these patients compared with the baseline data.Because of the progressive nature of MPS II, early diagnosis via a newborn screening program and timely initiation of ERT and/or HSCT before the occurrence of irreversible organ damage may lead to better clinical outcomes. The findings of the current study could serve as baseline data for the analysis of the long-term effects of ERT and HSCT in these patients." @default.
• W4283362395 created "2022-06-25" @default.
• W4283362395 creator A5003773418 @default.
• W4283362395 creator A5004782890 @default.
• W4283362395 creator A5014550528 @default.
• W4283362395 creator A5019798190 @default.
• W4283362395 creator A5025544238 @default.
• W4283362395 creator A5025894141 @default.
• W4283362395 creator A5027663283 @default.
• W4283362395 creator A5031629187 @default.
• W4283362395 creator A5047228974 @default.
• W4283362395 creator A5047699221 @default.
• W4283362395 creator A5068424735 @default.
• W4283362395 creator A5072203243 @default.
• W4283362395 creator A5078858242 @default.
• W4283362395 creator A5079126772 @default.
• W4283362395 creator A5081260981 @default.
• W4283362395 date "2022-06-21" @default.
• W4283362395 modified "2023-09-28" @default.
• W4283362395 title "Newborn Screening Program for Mucopolysaccharidosis Type II and Long-Term Follow-Up of the Screen-Positive Subjects in Taiwan" @default.
• W4283362395 cites W1480125634 @default.
• W4283362395 cites W1983365042 @default.
• W4283362395 cites W1990892818 @default.
• W4283362395 cites W1993027304 @default.
• W4283362395 cites W1994657204 @default.
• W4283362395 cites W2010188647 @default.
• W4283362395 cites W2010429932 @default.
• W4283362395 cites W2030045021 @default.
• W4283362395 cites W2044026349 @default.
• W4283362395 cites W2049493223 @default.
• W4283362395 cites W2058997980 @default.
• W4283362395 cites W2065001163 @default.
• W4283362395 cites W2084024032 @default.
• W4283362395 cites W2088174647 @default.
• W4283362395 cites W2103457363 @default.
• W4283362395 cites W2110978695 @default.
• W4283362395 cites W2111439770 @default.
• W4283362395 cites W2116587201 @default.
• W4283362395 cites W2117500144 @default.
• W4283362395 cites W2124364276 @default.
• W4283362395 cites W2141904817 @default.
• W4283362395 cites W2148045371 @default.
• W4283362395 cites W2330582066 @default.
• W4283362395 cites W2338756338 @default.
• W4283362395 cites W2345935183 @default.
• W4283362395 cites W2346556754 @default.
• W4283362395 cites W2473662354 @default.
• W4283362395 cites W2514953815 @default.
• W4283362395 cites W2526629344 @default.
• W4283362395 cites W2617895008 @default.
• W4283362395 cites W2621730333 @default.
• W4283362395 cites W2805116397 @default.
• W4283362395 cites W2807641839 @default.
• W4283362395 cites W2890928166 @default.
• W4283362395 cites W2899889744 @default.
• W4283362395 cites W2916665686 @default.
• W4283362395 cites W2951642052 @default.
• W4283362395 cites W2952168997 @default.
• W4283362395 cites W2963433951 @default.
• W4283362395 cites W2980184908 @default.
• W4283362395 cites W2996307640 @default.
• W4283362395 cites W3082276934 @default.
• W4283362395 cites W3093116773 @default.
• W4283362395 cites W3095081087 @default.
• W4283362395 cites W3197845424 @default.
• W4283362395 cites W4220874979 @default.
• W4283362395 doi "https://doi.org/10.3390/jpm12071023" @default.
• W4283362395 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35887520" @default.
• W4283362395 hasPublicationYear "2022" @default.
• W4283362395 type Work @default.
• W4283362395 citedByCount "4" @default.
• W4283362395 countsByYear W42833623952022 @default.
• W4283362395 countsByYear W42833623952023 @default.
• W4283362395 crossrefType "journal-article" @default.
• W4283362395 hasAuthorship W4283362395A5003773418 @default.
• W4283362395 hasAuthorship W4283362395A5004782890 @default.
• W4283362395 hasAuthorship W4283362395A5014550528 @default.
• W4283362395 hasAuthorship W4283362395A5019798190 @default.
• W4283362395 hasAuthorship W4283362395A5025544238 @default.
• W4283362395 hasAuthorship W4283362395A5025894141 @default.
• W4283362395 hasAuthorship W4283362395A5027663283 @default.
• W4283362395 hasAuthorship W4283362395A5031629187 @default.
• W4283362395 hasAuthorship W4283362395A5047228974 @default.
• W4283362395 hasAuthorship W4283362395A5047699221 @default.
• W4283362395 hasAuthorship W4283362395A5068424735 @default.
• W4283362395 hasAuthorship W4283362395A5072203243 @default.
• W4283362395 hasAuthorship W4283362395A5078858242 @default.
• W4283362395 hasAuthorship W4283362395A5079126772 @default.
• W4283362395 hasAuthorship W4283362395A5081260981 @default.
• W4283362395 hasBestOaLocation W42833623951 @default.
• W4283362395 hasConcept C126322002 @default.
• W4283362395 hasConcept C187212893 @default.
• W4283362395 hasConcept C2776169613 @default.
• W4283362395 hasConcept C2776225084 @default.
• W4283362395 hasConcept C2777408962 @default.
• W4283362395 hasConcept C2778264360 @default.
• W4283362395 hasConcept C2779134260 @default.
• W4283362395 hasConcept C2779416428 @default.

• next